Zeatin metabolites were isolated from seedcoats and pod tissues of Phaseolus vulgaris and P. lunatus. The differences observed previously between P. vulgaris and P. lanatus embryos, i.e. the formation of 0-ribosyl derivatives in the former and 0-glucosyl derivatives in the latter, could also be detected in seedcoats, although the levels of these metabolites were much lower and there was a concomitant increase of breakdown products (adenine, adenosine and AMP). Inner pod wall tissues of both genotypes metabolized zeatin at a slow rate and the major metabolite was the mononucleotide of zeatin. The array of metabolites recovered was not influenced by the extraction method (cold ethanol or modified Bieleski solution).
The metabolism of [14-C]zeatin2 was recently examined in embryos of Phaseolus vulgaris cv Great Northern (GN) and P. lunatus cv Kingston (K) (5) . Five major metabolites were recovered from P. vulgaris embryo extracts: ribosylzeatin, ribosylzeatin 5'-monophosphate, an O-glucoside of ribosylzeatin and two novel compounds (designated as metabolites I and II, and breakdown products (Ade, Ado, and AMP) were calculated as per cent ofthe recovered radioactivity. The amount of recovery was estimated by adding radioactivity of all HPLC fractions after subtracting the background. The array and amounts ofzeatin metabolites recovered from embryos, seedcoat, and pod tissues ofGN and K after 1 h ofincubation are presented in Table I . After 1 h incubation, GN embryos had converted large amounts (63%) of zeatin to metabolite I. In embryos of K, Table I the major metabolites were the O-glucoside and mononucleotide of zeatin. The levels of breakdown products (Ade, Ado, and AMP) were low in embryos of both genotypes. Seedcoat tissues of both genotypes, however, yielded much larger amounts of breakdown products as compared with embryos. The levels of metabolite I (in GN) and OGZ (in K) were also much lower. Pod tissues did not seem to metabolize zeatin actively, judging from the relatively high level of zeatin recovered. The major metabolite in both genotypes was the mononucleotide of zeatin.
Thus, it appears that pronounced interspecific differences in zeatin metabolism occur in the seeds but not in the pods.
No consistent different could be detected between methods of extracting zeatin metabolites. In Kingston tissues, ethanol extraction recovered a larger amount of label (approximately 10% higher) and a substantially lower amount ofbreakdown products. For example, in seedcoat and pod tissues, 40 and 16% of the label recovered were breakdown products using Bieleski solution, whereas ethanol extraction resulted in only 16 and 8% of Ade, Ado, and AMP. However, in Great Northern tissues, the radioactivity recovered with Bieleski solution was slightly higher (10, 4, and 7% higher for embryo, seedcoat, and pod tissues). The amount of ZMP recovered using both methods of extraction were similar but varied with the genotype and the tissues. One of the advocated advantages of Bieleski solution was the higher recovery of nucleotides via effective inhibition of phosphatase activities; the results obtained here, however, indicate that cold ethanol is adequate in extracting zeatin metabolites in a variety of Phaseolus tissues.
